Desuden mindske - des antallet af hvide blodlegemer med Philadelphia- kromosomet hos mellem en tredjedel og to tredje - dele af patienterne i de fem hovedundersøgelser.
In addition, between one and two thirds of the patients in the five main trials showed a reduction in the number of white blood cells containing the Philadelphia chromosome.